EverHint – Dip Bounce V2 (Reclaim) – Top 10 Signals for Oct 15, 2026
Excerpt: 10 signals (from 66 total). Healthcare leads (15). price range $12-$132. 2 with insider selling.
What This Signal Is
Production-ready dip-bounce strategy using reclaim pattern with Phase 2 market regime filters. Improved win rate from 40.42% (V1) to 50.18% (V2) with VIX and record high filters.
Entry Criteria:
- Minimum dip: 3.3% (open to intraday low)
- Minimum bounce: 1.0% from low
- Net change range: -2.0% to +0.3%
- Price above SMA(200)
- Minimum ADV: $40M
Holding period: 1-5 days | Risk level: Medium
Market Context
Equity markets are trading in broadly positive territory, with the Dow Jones leading gains at +1.08% while the Nasdaq lags with a modest +0.08% advance. This divergence suggests rotation away from high-multiple growth names and toward more value-oriented, cyclical, and defensive sectors — a backdrop that naturally elevates Healthcare's prominence as the top signal-generating sector. The risk-on tone is tempered but constructive, indicating traders are selectively deploying capital rather than chasing momentum broadly.
Volatility conditions are notably supportive for dip-bounce strategies. The VIX at 16.46, down -2.43% on the session, sits in a moderate range — low enough to reflect relative calm, but not so compressed that it eliminates meaningful intraday price swings. This is a favorable environment for dip_bounce_v2_reclaim setups, as stocks can experience short-term pullbacks with enough volatility to trigger entry signals while the broader market stabilizes and reclaims key levels without excessive whipsaw risk.
The sector rotation dynamic reinforces the signal cluster in Healthcare, which tends to attract defensive capital when growth leadership fades — as evidenced by the Nasdaq's underperformance today. With 66 total signals generated, the breadth suggests broad participation across names exhibiting reclaim behavior, rather than concentration in a single pocket of the market. Traders should be aware that while the overall tape is supportive, the subdued Nasdaq momentum may limit follow-through on any growth-adjacent Healthcare names, making confirmation of reclaim levels particularly important before sizing into positions.
📊 Signals (10 of 66 total)
Ranked by dip magnitude (highest first)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | MTCH | Match Group, Inc. | Communication Services | $44.10 | 0.37 | — | $10.1B |
| 2 | GEN | Gen Digital Inc. | Technology | $24.82 | 0.31 | — | $14.9B |
| 3 | CHA | Chagee Holdings Limite... | Consumer Defensive | $12.44 | 0.29 | — | $2.4B |
| 4 | RNG | RingCentral, Inc. | Technology | $79.94 | 0.26 | — | $5.9B |
| 5 | MDT | Medtronic Plc | Healthcare | $95.45 | 0.24 | — | $122.1B |
| 6 | UAN | CVR Partners, LP | Basic Materials | $132.22 | 0.22 | — | $1.4B |
| 7 | PAYX | Paychex, Inc. | Technology | $110.78 | 0.22 | — | $39.4B |
| 8 | CF | CF Industries Holdings... | Basic Materials | $119.77 | 0.20 | — | $18.1B |
| 9 | NRIX | Nurix Therapeutics, Inc. | Healthcare | $24.95 | 0.19 | — | $2.6B |
| 10 | SIRI | Sirius XM Holdings Inc. | Communication Services | $27.15 | 0.19 | — | $9.2B |
Recent Headlines
SIRI (Sirius XM Holdings Inc.)
- Sirius XM (SIRI) Exceeds Market Returns: Some Facts to Consider
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.